Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Faron Pharmaceuticals Oy

Finland Joukahaisenkatu 6, 20520 Turku, Finland

About the sponsor

Faron Pharmaceuticals Oy focuses on hematologic malignancies, with clinical research centered on malignant disorders of the blood and bone marrow.

  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome

The sponsor’s research activity in this area is directed toward treatment settings where standard of care remains a key component of therapy.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Study of Bexmarilimab Combined with Standard Treatment for Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Not recruiting
InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bexmarilimab
  • Sponsor:Faron Pharmaceuticals Oy

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.